by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

SnugZ USA, Inc. Warning Letter Details

Warning Letter

SnugZ USA, Inc.

Recipient Title President and Chief Executive Officer, SnugZ USA, Inc., 9258 South Prosperity Road West Jordan , UT 84081-6161 United States

Issue DateSeptember 28, 2026

FEI Number3009188709

Violations5

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

SnugZ USA, Inc. FDA Warning Letter, September 28, 2026